Adaptive Biotechnologies Insider Sold Shares Worth $879,088
An insider at Adaptive Biotechnologies Corporation has sold company shares valued at approximately $879,088.
Stocks · News reference
Adaptogenics Health Corp. has scheduled its Annual General and Special (AGS) meeting for December 18, 2026, with a record date of November 13, 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
An insider at Adaptive Biotechnologies Corporation has sold company shares valued at approximately $879,088.
TD Cowen analyst Dan Brennan maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and raises the price target from $28 to $32.
Morgan Stanley analyst Tejas Savant maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Equal-Weight and raises the price target from $22 to $27.